NCT02286089: Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 24 taking part
- Started
- 1 Apr 2015
- Primary completion
- 31 Dec 2021
- Arms
- OpRegen
- Results
- Posted on the registry
- 7 Nov 2014: Trial registered
- 1 Apr 2015: Trial started
- 6 Mar 2023: Trial results posted